International Cancer Imaging Society Development Site

International Cancer Imaging Society Meeting and 18th Annual Teaching Course

  Advancing Cancer Imaging:   

  Improving Patient Outcomes  

Sun 07 Oct 2018 - Tue 09 Oct 2018

Palais de l’Europe, Menton, France

Meeting President: Prof. Wim Oyen, London, UK

» Further Information  

» Register Here  

» Submit an Abstract - Deadline 4th June 

Interactive Workshops

These one day teaching courses are limited to 20 participants, each with their own imaging workstation and content delivered through lectures and hands-on case based learning.

Courses in 2018

Masterclass in Imaging of Gynaecological Cancer, London, Thu 01 Nov

» More Information   Register Now! 


Other Courses in 2018

Masterclass in Imaging of Oncological Whole Body MRI, London, Thu 08 Nov

If you would like to be kept updated about our courses please scroll down and register your interest in the turquoise box at the bottom of the homepage.

Join our Society

Do you believe that Cancer Imaging is important?

If your answer is yes, join us to support and promote the education in oncological imaging and stimulate research in the study of human tumour behaviour.

As a member you will also receive:

  • Discounted registration fees for all our teaching courses
  • Exclusive access to the members' area
  • Exclusive access to posters and presentations from the annual teaching course
  • 20% off the APC for submitting manuscripts to Cancer Imaging

» Join now 

About ICIS

The International Cancer Imaging Society exists to meet the important challenges of advancing imaging in the multidisciplinary management of cancer.

We promote education in oncological imaging and stimulate research in the study of human tumour behaviour, bringing together radiologists with an interest in oncological imaging for the exchange of ideas, and to organise scientific meetings, multicentre research studies and postgraduate courses within the field.


» Latest News 

Cancer Imaging Journal

Impact Factor 2.404

Cancer Imaging is the official journal of ICIS, it is an open access, peer-reviewed journal with original articles as well as reviews and editorials.  The journal encompasses CT, MRI, ultrasound, single photon and positron emission tomography, including multimodality imaging in all kinds of malignant tumours, plus new developments, techniques and innovations.

A fantastic course covering a broad spectrum of topics related to oncologic imaging.  Up to date and relevant subject matter.  Great interactive sessions.  Well organised. I recommend the course for radiology trainees and consultants.

JF | Newcastle, UK

Register your interest for all ICIS courses

Please click on the link below to register your interest for future ICIS interactive courses.  We will notify you in advance of registration opening, allowing you first refusal on our popular courses.

To register your interest, fill in the details below and click on the "Register Interest" button.

Join our mailing list

If you want to be kept up to date on what's happening with ICIS, click on the "Subscribe" button below.

Cancer / Oncology News From Medical News Today

What is the difference between a cyst and a tumor?

Published: Tue, 22 May 2018 05:00:00 PDT

While cysts and tumors may look and feel similar, there are key differences. Hearing the word “tumor” may be frightening, but many tumors are benign, and while some cysts are harmless, others can cause problems. In this article, learn the difference between cysts and tumors. We also describe conditions that cause them.

Could Viagra and a flu shot kill cancer?

Published: Mon, 21 May 2018 09:00:00 PDT

A Viagra, Cialis, and inactivated flu vaccine combination reduced cancer spread in a mouse model of post-surgery metastasis by helping the immune system.

Lung cancer destroyed with tea leaf nanoparticles

Published: Mon, 21 May 2018 07:00:00 PDT

Researchers destroyed up to 80 percent of lung cancer cells using a type of nanoparticle called 'quantum dots,' which they derived from tea leaves.

Lowering cholesterol improves cancer-fighting immunotherapy

Published: Sat, 19 May 2018 00:00:00 PDT

A recent study demonstrates that a certain type of cancer immunotherapy might be enhanced simply by reducing cholesterol levels in cells.

This 'metastasis-blocking' compound may stop the spread of cancer

Published: Fri, 18 May 2018 09:00:00 PDT

A compound that targets a unique structure in cancer cell nuclei and has links to metastasis potential stopped cancer spread and extended survival in mice.

Do eyelashes grow back? What you need to know

Published: Fri, 18 May 2018 05:00:00 PDT

Losing a few eyelashes from time to time is normal. However, sometimes a person loses many or all of their eyelashes, perhaps as a result of a burn, a medical therapy, or a health condition. In this article, learn how quickly the eyelashes grow back, as well as treatments and home remedies to help the process.

Why is lung cancer so difficult to treat?

Published: Thu, 17 May 2018 09:00:00 PDT

Immunotherapies often fail to halt lung cancer's progression. A new study attempts to understand why this is and design a new way to attack it.

What could cause bone pain?

Published: Thu, 17 May 2018 05:00:00 PDT

People may feel aches or pains in their bones for a variety of reasons. Many people worry when they experience bone pain because it can be a sign of bone cancer. For this reason, prompt diagnosis is essential. Learn more about bone pain symptoms, the signs of cancer, and when to see a doctor.

What is Demodex folliculorum?

Published: Thu, 17 May 2018 03:00:00 PDT

Demodex folliculorum is a mite that lives on the face. For most people, their presence is harmless. However, in larger numbers, they can cause skin problems. This is more likely in people with certain skin conditions or weakened immune systems. We look at the causes, symptoms, and treatments of Demodex folliculorum.

Cancer: Does sex affect the outcome of immunotherapy?

Published: Thu, 17 May 2018 00:00:00 PDT

Therapies that help the immune system to fight tumors have gained popularity over time. But are we leaving a key element — sex — out of clinical trials?

Could gut bacteria drive colon cancer?

Published: Wed, 16 May 2018 07:00:00 PDT

Could gut bacteria impact the development of colon cancer by interacting with molecules that help to regulate gene expression? A recent study investigates.

Colorectal cancer: Some cells are 'born to be bad'

Published: Tue, 15 May 2018 09:00:00 PDT

A small study finds that genetic signatures for cell migration and metastasis are already present in early malignant — but not benign — colorectal tumors.

Deadly brain cancer stopped with new compound

Published: Mon, 14 May 2018 08:00:00 PDT

New research shows that using an experimental enzyme-blocker stops brain tumors from growing and limits the ability of human cancer cells to replicate.

Can women get prostate cancer?

Published: Mon, 14 May 2018 04:00:00 PDT

Women do not have a prostate in the same way as men. They do, however, have Skene glands, often called the female prostate, which have many similarities to the prostate. Cancer of the female prostate is extremely rare. Find out about the functions of the Skene glands and learn more about female prostate cancer here.

What to know about multinodular goiter

Published: Sun, 13 May 2018 03:00:00 PDT

A multinodular goiter is an enlarged thyroid gland with several nodules. It may not cause any symptoms, but a large goiter can cause difficulty breathing or swallowing or be related to hyperthyroidism. Learn more about the symptoms, causes, and treatments for multinodular goiter, and its relation to cancer here.

How long will I survive after a liver transplant?

Published: Thu, 10 May 2018 00:00:00 PDT

Liver transplant surgery is the second most common transplant surgery in the U.S. Livers typically come from deceased donors, but transplants using parts of livers from live donors are becoming more frequent. Figures show that more than 50 percent of people who have a liver transplant survive for at least 20 years.

Body clock gene may protect against breast cancer

Published: Thu, 10 May 2018 00:00:00 PDT

One of the genes that regulate our circadian rhythm might also contribute to the normal development of mammary glands and protect against breast cancer.

Why ovarian cancer spreads and how we might stop it

Published: Wed, 09 May 2018 09:00:00 PDT

A new study unlocks the mystery of ovarian cancer metastasis. The findings may lead to new treatments, using existing drugs to stop tumors from spreading.

Scientists may have found 'best time' to administer chemo drugs

Published: Wed, 09 May 2018 08:00:00 PDT

A genome-wide map of busiest DNA repair times could reduce chemotherapy damage to healthy tissue through optimum 24-hour timing of dosage, say researchers.

New protein may help to catch lung cancer early

Published: Wed, 09 May 2018 00:00:00 PDT

Japanese-based researchers have uncovered a biomarker that may help to diagnose lung cancer much earlier than the current tests can.